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P=0.000Table 2. Adjusted HRs for death or dialysis within ICU from a
multivariate Cox proportional hazards model
Variable Adjusted HR(95% CI) P ValueNephrocheck positivity 2.038(1.285-3.234) 0.003CKD 1.776(1.060-2.974) 0.029SOFA score 1.109(1.045-1.176) 0.001Lactate on admission 1.070(1.014-1.130) 0.014Creatinine on admission 1.175(1.017-1.356) 0.028Conclusions: The [TIMP-2][IGFBP7] product offers an excellent tool
for early recognition of AKI risk where intervention can still alter
outcomes. It has been validated in previous cohorts, over-performing
other biomarkers in the detection of AKI. Our vision was to expand
further on other potential uses of [TIMP-2][IGFBP7]. To our knowl-
edge, this is the first study that combines [TIMP-2][IGFBP7] values
with the clinical diagnosis of AKI to investigate the risk of developing
worse outcomes in critically-ill patients. Our study shows that
the [TIMP-2][IGFBP7] values not only predict AKI risk, but also can
serve to identify AKI patients at increased risk for adverse outcomes
in ICU.
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Introduction:Acute kidney injury (AKI) is a well-defined risk factor for
the development of chronic kidney disease. Group 2 innate lymphoid
cells (ILC2s) are critical regulators of tissue homeostasis and are resident
in the kidney. Recent evidence suggests that experimentally increasing
the numbers of ILC2s with systemic recombinant mouse interleukin
(IL)‑25 or IL‑33 administration prior to, or following, experimental AKI
is protective against early features of renal injury. Whilst these cells can
be induced to proliferate and protect against the deleterious conse-
quences of ischemic or chemically-induced AKI, the impact of ILC2
deficiency on the severity of renal injury is unknown.Methods: ILC2s were identified in kidney homogenates from wild-type
(WT) C57BL/6JAusB and IL-5 reporter (Il5venus/+) mice using flow
cytometry, which was confirmed using immunofluorescence in kidney
sections from IL-5 reporter (Rosatd-tomato/+Il5cre/+) mice. To assess the
role of ILC2s in renal injury, we used an experimental model of AKI
induced by 29-minute ischemia-reperfusion injury (IRI) following a
contralateral nephrectomy in male WT, ILC2-deficient (Rorafl/flIl7rcre/+)
and diphtheria toxoid (DTx)-mediated ILC2-depleted (DTx treated
Icosdtr/+Cd4cre/+) mice. Heterozygote (Rorafl/+Il7rcre/+) and vehicle
controls (saline treated Icosdtr/+Cd4cre/+) were examined alongside the
experimental injury. Sham controls for each genotype received a
contralateral nephrectomy only.
Results: An extracellular matrix and adhesion molecules PCR array
revealed that mRNA expression of 26/84 targets were increased greater
than two-fold, 7-days post-IRI, compared to sham surgery. Histopath-
ological features of acute tubular necrosis occurred 7 days after IRI in
the form of dilated tubules, apoptotic tubules with loss of bush border
and cast formation, which were not present following sham surgery.
Remodelling was assessed with mason’s trichrome staining. At 7 days
post-IRI there was increased collagen content between the tubules
scattered throughout the medulla and cortex of the kidney, which was
not present in the sham controls. Since injury and remodelling were
present at day 7 in WT mice, this time point was used to assess the role
of ILC2-deficiency and -depletion. There were no differences in histo-
pathological score (H&E and PAS kidney sections), collagen deposition
(masons trichrome stained sections) or mRNA expression of injury-
associated factors (Lcn2 and Tnf); inflammatory chemokines (Ccl5,
Ccl20, Cxcl1, Cxcl2 and Cxcl10); tissue remodelling and fibrotic factors
(Col1a1, Fn1 and Tgfb1); and an ILC2-related growth factor (Areg) in
kidney homogenate relative to Hprt in ILC2-deficient or -depleted mice
compared to their appropriate ILC2-sufficient controls. There was 100%
survival, irrespective of genotype.
Conclusions: These data demonstrate that the absence of ILC2s does not
alter the severity of AKI. The existing literature suggests that activation
of ILC2s and production of local type 2 immunity is protective against
AKI. ILC2s are likely contributors, but other mechanisms of type 2-
mediated immune activation may compensate in the absence of ILC2s. A
loss of ILC2s is unlikely to increase susceptibility to, or severity of AKI,
but they remain an attractive target for cellular therapies.
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Introduction: Renal medullary hypoxia may be a pathophysiological
factor in cardiac surgery-associated acute kidney injury. However, the
effects of cardiopulmonary bypass (CPB) on oxygenation of the renal
medulla remainpoorlyunderstood. Furthermore,whether increasedpump
flow or arterial pressure can improve renal medullary oxygenation has not
been determined. Therefore, in the current study we tested whether CPB
causes medullary hypoxia and whether medullary oxygenation during
CPB varies with pump flow and mean arterial pressure.
Methods: Twelve sheep were instrumented to allow measurement of
whole kidney, medullary and cortical blood flow and oxygenation. The
experiment was performed five days later, under isoflurane anesthesia.
Sheep were first placed on CPB at a pump flow of 80 mL/kg/min and a
target mean arterial pressure of 70 mmHg. Pump flow was then set at 60
and 100 mL/kg/min while mean arterial pressure was maintained at ~70
mmHg. Mean arterial pressure was then increased by infusion of
metaraminol (0.2 mg/min) at a set pump flow of 80 mL/kg/min.
Results: Transition to CPB at a pump flow of 80 ml/kg/min was associated
with reduced total renal blood flow (RBF, -61% less than the conscious
state), along with reduced perfusion in the cortex (-44%) and medullaS59
